Huntington’s Disease is a neurological condition that can bring on intellectual deterioration, leading to dementia. It is accompanied by symptons of depression and involuntary abnormal body movements. It is a rare condition that usually occurs between the ages of 35 and 50 years, often leading to death in the following 15 to 20 years.
Researchers at the Institut Curie, CNRS and Inserm have shown that cysteamine, which is already used to treat Cystinosis, can help prevent the death of neurons in the brain and hence be used to treat Huntington’s Disase.
More on this research can be found at http://www.innovations-report.de.